Author:
Luque Paz Damien,Cottin Laurane,Lippert Eric,Robin Jean-Baptiste,Bescond Charles,Genevieve Franck,Boyer Françoise,Quintin-Roue Isabelle,Rousselet Marie-Christine,Burroni Barbara,Hunault-Berger Mathilde,Ugo Valérie,Ianotto Jean-Christophe,Orvain Corentin
Publisher
Springer Science and Business Media LLC
Subject
Hematology,General Medicine
Reference15 articles.
1. Barosi G, Viarengo G, Pecci A et al (2001) Diagnostic and clinical relevance of the number of circulating CD34(+) cells in myelofibrosis with myeloid metaplasia. Blood 98(12):3249–3255
2. Andréasson B, Swolin B, Kutti J (2002) Patients with idiopathic myelofibrosis show increased CD34+ cell concentrations in peripheral blood compared to patients with polycythaemia vera and essential thrombocythaemia. Eur J Haematol 68(4):189–193
3. Passamonti F, Vanelli L, Malabarba L et al (2003) Clinical utility of the absolute number of circulating CD34-positive cells in patients with chronic myeloproliferative disorders. Haematologica 88(10):1123–1129
4. Arora B, Sirhan S, Hoyer JD, Mesa RA, Tefferi A (2005) Peripheral blood CD34 count in myelofibrosis with myeloid metaplasia: a prospective evaluation of prognostic value in 94 patients. Br J Haematol 128(1):42–48
5. Arber DA, Orazi A, Hasserjian R et al (2016) The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 127(20):2391–2405